A comparison of the cell lines used in meningioma research

Surgical Neurology

Volumn 70, Issue 3, 2008, Pages 295-307

  Ragel, Brian T ^a,b   Couldwell, William T ^a,b   Gillespie, David L ^a,b   Wendland, Merideth M ^a,b   Whang, Kum ^b,c   Jensen, Randy L ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c Yonsei University Wonju   (South Korea)

Author keywords

CH 157 MN; IOMM Lee; Meningioma; Xenograft mouse model

Indexed keywords

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KARYOTYPE; MALE; MEDICAL RESEARCH; MENINGIOMA; MOUSE; NONHUMAN; XENOGRAFT;

ADULT; AGED; ANIMALS; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; DISEASE MODELS, ANIMAL; FEMALE; GENOTYPE; GRAFT SURVIVAL; HUMANS; KI-67 ANTIGEN; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MICE; MICE, NUDE; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; NEOPLASM INVASIVENESS; TUMOR MARKERS, BIOLOGICAL; VIMENTIN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 48549107311     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surneu.2007.06.031     Document Type: Article

References (43)

1. Akat K., Mennel H.D., Kremer P., et al. Molecular characterization of desmosomes in meningiomas and arachnoidal tissue. Acta Neuropathol (Berl) 106 (2003) 337-347
2. Al-Rodhan R.F., and Laws E.R. The history of intracranial meningiomas. In: Al-Mefty O. (Ed). Meningiomas (1991), Raven Press, Ltd., New York 1-6
3. Al Saadi A., Latimer F., Madercic M., et al. Cytogenetic studies of human brain tumors and their clinical significance. II. Meningioma. Cancer Genet Cytogenet 26 (1987) 127-141
4. Bigner S.H., Mark J., and Bigner D.D. Cytogenetics of human brain tumors. Cancer Genet Cytogenet 47 (1990) 141-154
5. Bostrom J., Meyer Puttlitz B., Wolter M., et al. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Am J Pathol 159 (2001) 661-669
6. In: Burger P.C., Scheithauer B.W., and Vogel F.S. (Eds). Surgical pathology of the nervous system and its coverings. 4th ed. (2002), Churchhill Livingstone, Philadelphia
7. Cai D.X., Banerjee R., Scheithauer B.W., et al. Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications. J Neuropathol Exp Neurol 60 (2001) 628-636
8. Cai D.X., James C.D., Scheithauer B.W., et al. PS6K amplification characterizes a small subset of anaplastic meningiomas. Am J Clin Pathol 115 (2001) 213-218
9. Dumanski J.P., Rouleau G.A., Nordenskjold M., et al. Molecular genetic analysis of chromosome 22 in 81 cases of meningioma. Cancer Res 50 (1990) 5863-5867
10. Gonzales M.F. Classification of brain tumors. In: Kaye A.H., and Laws E.R. (Eds). Brain Tumors. 1st ed. (1995), Churchill Livingstone, Edinburgh 675
11. Greene H.S., and Arnold H. The homologous and heterologous transplantation of brain and brain tumors. J Neurosurg 2 (1945) 315-329
12. Jensen R.L., Lee Y.S., Guijrati M., et al. Inhibition of in vitro meningioma proliferation after growth factor stimulation by calcium channel antagonists: part II-additional growth factors, growth factor receptor immunohistochemistry, and intracellular calcium measurements. Neurosurgery 37 (1995) 937-946 [Discussion 946-7]
13. Jensen R.L., Leppla D., Rokosz N., et al. Matrigel augments xenograft transplantation of meningioma cells into athymic mice. Neurosurgery 42 (1998) 130-135 [Discussion 135-6]
14. Jensen R.L., Origitano T.C., Lee Y.S., et al. In vitro growth inhibition of growth factor-stimulated meningioma cells by calcium channel antagonists. Neurosurgery 36 (1995) 365-373 [Discussion 373-4]
15. Jensen R.L., and Wurster R.D. Calcium channel antagonists inhibit growth of subcutaneous xenograft meningiomas in nude mice. Surg Neurol 55 (2001) 275-283
16. Katsuyama J., Papenhausen P.R., Herz F., et al. Chromosome abnormalities in meningiomas. Cancer Genet Cytogenet 22 (1986) 63-68
17. Lamszus K., Kluwe L., Matschke J., et al. Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas. Cancer Genet Cytogenet 110 (1999) 103-110
18. Lee W.H. Characterization of a newly established malignant meningioma cell line of the human brain: IOMM-Lee. Neurosurgery 27 (1990) 389-395 [Discussion 396]
19. Lekanne Deprez R.H., Bianchi A.B., Groen N.A., et al. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet 54 (1994) 1022-1029
20. Leon S.P., Zhu J., and Black P.M. Genetic aberrations in human brain tumors. Neurosurgery 34 (1994) 708-722
21. Louis D.N., Scheithauer B.W., Budka H., et al. Meningiomas. In: Kleihues P., and Cavenee W.K. (Eds). World Health Organization classification of tumours: pathology and genetics: tumours of the nervous system (2000), IARC Press, Lyon 176-189
22. Mahmood A., Caccamo D.V., Tomecek F.J., et al. Atypical and malignant meningiomas: a clinicopathological review. Neurosurgery 33 (1993) 955-963
23. Martuza R.L., Malick A., Markert J.M., et al. Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 252 (1991) 854-856
24. McCutcheon I.E., Friend K.E., Gerdes T.M., et al. Intracranial injection of human meningioma cells in athymic mice: an orthotopic model for meningioma growth. J Neurosurg 92 (2000) 306-314
25. Medhkour A., Van Roey M., Sobel R.A., et al. Implantation of human meningiomas into the subrenal capsule of the nude mouse. A model for studies of tumor growth. J Neurosurg 71 (1989) 545-550
26. Olson J.J., Beck D.W., Schlechte J.A., et al. Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice. J Neurosurg 66 (1987) 584-587
27. Ozaki S., Nishizaki T., Ito H., et al. Comparative genomic hybridization analysis of genetic alterations associated with malignant progression of meningioma. J Neurooncol 41 (1999) 167-174
28. Prempree T., Amornmarn R., Faillace W.J., et al. 1;19 translocation in human meningioma. Cancer 71 (1993) 2306-2311
29. Ragel B.T., and Jensen R.L. Molecular genetics of meningiomas. Neurosurg Focus 19 5 (2005) E9
30. Rana M.W., Pinkerton H., Thornton H., et al. Heterotransplantation of human glioblastoma multiforme and meningioma to nude mice. Proc Soc Exp Biol Med 155 (1977) 85-88
31. Rutka J.T., Giblin J., Dougherty D.V., et al. An ultrastructural and immunocytochemical analysis of leptomeningeal and meningioma cultures. J Neuropathol Exp Neurol 45 (1986) 285-303
32. Schneider B.F., Shashi V., von Kap-herr C., et al. Loss of chromosomes 22 and 14 in the malignant progression of meningiomas. A comparative study of fluorescence in situ hybridization (FISH) and standard cytogenetic analysis. Cancer Genet Cytogenet 85 (1995) 101-104
33. Seizinger B.R., de la Monte S., Atkins L., et al. Molecular genetic approach to human meningioma: loss of genes on chromosome 22. Proc Natl Acad Sci U S A 84 (1987) 5419-5423
34. Simon M., von Deimling A., Larson J.J., et al. Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression. Cancer Res 55 (1995) 4696-4701
35. Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurochem 20 (1957) 22-39
36. Tsai J.C., Goldman C.K., and Gillespie G.Y. Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. J Neurosurg 82 (1995) 864-873
37. Tsai J.C., Hsiao Y.Y., Teng L.J., et al. Regulation of vascular endothelial growth factor secretion in human meningioma cells. J Formos Med Assoc 98 (1999) 111-117
38. Ueyama Y., Morita K., Ochiai C., et al. Xenotransplantation of a human meningioma and its lung metastasis in nude mice. Br J Cancer 37 (1978) 644-647
39. Vagner Capodano A.M., Grisoli F., Gambarelli D., et al. Correlation between cytogenetic and histopathological findings in 75 human meningiomas. Neurosurgery 32 (1993) 892-900 [Discussion 900]
40. van Furth W.R., Laughlin S., Taylor M.D., et al. Imaging of murine brain tumors using a 1.5 Tesla clinical MRI system. Can J Neurol Sci 30 (2003) 326-332
41. Weber R.G., Bostrom J., Wolter M., et al. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci U S A 94 (1997) 14719-14724
42. Wellenreuther R., Kraus J.A., Lenartz D., et al. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol 146 (1995) 827-832
43. Wolff R.K., Frazer K.A., Jackler R.K., et al. Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors. Am J Hum Genet 51 (1992) 478-485